FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
381 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Xareltorivaroxaban | Rivaroxaban 20 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | NDA | 50090-3639 | 50090-3639-00 | — |
| Xareltorivaroxaban | Rivaroxaban 20 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | NDA | 50090-4468 | 50090-4468-00 | — |
| Xareltorivaroxaban | Rivaroxaban 10 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | NDA | 50090-4469 | 50090-4469-00 | — |
| Xareltorivaroxaban | Rivaroxaban 155 mg/1 | Granule, For suspensionOral |
| Janssen Pharmaceuticals, Inc. |
| NDA |
| 50458-575 |
| 50458-0575-01 |
| — |
| Xareltorivaroxaban | Rivaroxaban 2.5 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | NDA | 50458-577 | 50458-0577-1050458-0577-1450458-0577-18+1 more | — |
|---|
| Xareltorivaroxaban | Rivaroxaban 15 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | NDA | 50458-578 | 50458-0578-0750458-0578-1050458-0578-30+1 more | — |
|---|
| Xareltorivaroxaban | Rivaroxaban 20 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | NDA | 50458-579 | 50458-0579-0750458-0579-1050458-0579-30+2 more | — |
|---|
| Xareltorivaroxaban | Rivaroxaban 10 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | NDA | 50458-580 | 50458-0580-0750458-0580-1050458-0580-30+1 more | — |
|---|
| Xareltorivaroxaban | — | Kit | Janssen Pharmaceuticals, Inc. | NDA | 50458-584 | 50458-0584-5150458-0584-52 | — |
|---|
| Xareltorivaroxaban | Rivaroxaban 20 mg/1 | Tablet, Film coatedOral | Cardinal Health 107, LLC | NDA | 55154-1423 | 55154-1423-08 | — |
|---|
| Xareltorivaroxaban | Rivaroxaban 15 mg/1 | Tablet, Film coatedOral | Cardinal Health 107, LLC | NDA | 55154-1424 | 55154-1424-08 | — |
|---|
| Xareltorivaroxaban | Rivaroxaban 10 mg/1 | Tablet, Film coatedOral | Aphena Pharma Solutions - Tennessee, LLC | NDA | 71610-690 | 71610-0690-42 | — |
|---|
| Xatmepmethotrexate | Methotrexate 2.5 mg/mL | SolutionOral | Azurity Pharmaceuticals, Inc. | NDA | 52652-2001 | 52652-2001-0152652-2001-06 | — |
|---|
| Xbofpen Multi-Purpose Treatmenttolnaftate 1% multi-purpose treatment | Tolnaftate 1 g/100mL | LiquidTopical | Wenzhou Yuyuan Pharmaceutical Co., Ltd. | OTC monograph drug | 87786-038 | 87786-0038-01 | — |
|---|
| Xbofpen Wart Removersalicylic acid 17% wart remover | Salicylic acid 17 g/100mL | LiquidTopical | Wenzhou Yuyuan Pharmaceutical Co., Ltd. | OTC monograph drug | 87786-008 | 87786-0008-01 | — |
|---|
| Xcopricenobamate | Cenobamate 25 mg/1 | Tablet, Film coatedOral | SK Life Science, Inc. | NDA | 71699-025 | 71699-0025-30 | — |
|---|
| Xcopricenobamate | Cenobamate 50 mg/1 | Tablet, Film coatedOral | SK Life Science, Inc. | NDA | 71699-050 | 71699-0050-3071699-0050-99 | — |
|---|
| Xcopricenobamate | Cenobamate 100 mg/1 | Tablet, Film coatedOral | SK Life Science, Inc. | NDA | 71699-100 | 71699-0100-30 | — |
|---|
| Xcopricenobamate | Cenobamate 150 mg/1 | Tablet, Film coatedOral | SK Life Science, Inc. | NDA | 71699-150 | 71699-0150-30 | — |
|---|
| Xcopricenobamate | Cenobamate 200 mg/1 | Tablet, Film coatedOral | SK Life Science, Inc. | NDA | 71699-200 | 71699-0200-30 | — |
|---|
| Xcopricenobamate | Cenobamate 12.5 mg/1 | TabletOral | SK Life Science, Inc. | NDA | 71699-204 | 71699-0204-14 | — |
|---|
| Xcopri Maintenance Packcenobamate | — | KitOral | SK Life Science, Inc. | NDA | 71699-103 | 71699-0103-56 | — |
|---|
| Xcopri Maintenance Packcenobamate | — | KitOral | SK Life Science, Inc. | NDA | 71699-104 | 71699-0104-56 | — |
|---|
| Xcopri Titration Packcenobamate | — | KitOral | SK Life Science, Inc. | NDA | 71699-201 | 71699-0201-28 | — |
|---|
| Xcopri Titration Packcenobamate | — | KitOral | SK Life Science, Inc. | NDA | 71699-202 | 71699-0202-28 | — |
|---|
| Xcopri Titration Packcenobamate | — | KitOral | SK Life Science, Inc. | NDA | 71699-203 | 71699-0203-28 | — |
|---|
| Xdemvylotilaner ophthalmic solution | Lotilaner 2.5 mg/mL | Solution/ dropsOphthalmic | Tarsus Pharmaceuticals, Inc. | NDA | 81942-125 | 81942-0125-0181942-0125-99 | — |
|---|
| Xeljanztofacitinib | Tofacitinib citrate 5 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-1001 | 00069-1001-01 | — |
|---|
| Xeljanztofacitinib | Tofacitinib citrate 10 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-1002 | 00069-1002-01 | — |
|---|
| Xeljanztofacitinib | Tofacitinib citrate 1 mg/mL | SolutionOral | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-1029 | 00069-1029-02 | — |
|---|
| Xeljanztofacitinib | Tofacitinib citrate 5 mg/1 | Tablet, Film coatedOral | U.S. Pharmaceuticals | NDA | 63539-012 | 63539-0012-02 | — |
|---|
| Xeljanztofacitinib | Tofacitinib citrate 10 mg/1 | Tablet, Film coatedOral | U.S. Pharmaceuticals | NDA | 63539-016 | 63539-0016-02 | — |
|---|
| Xeljanztofacitinib | Tofacitinib citrate 1 mg/mL | SolutionOral | U.S. Pharmaceuticals | NDA | 63539-029 | 63539-0029-02 | — |
|---|
| Xeljanz XRtofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-0501 | 00069-0501-30 | — |
|---|
| Xeljanz XRtofacitinib | Tofacitinib citrate 22 mg/1 | Tablet, Film coated, Extended releaseOral | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-0502 | 00069-0502-30 | — |
|---|
| Xeljanz XRtofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Extended releaseOral | U.S. Pharmaceuticals | NDA | 63539-501 | 63539-0501-30 | — |
|---|
| Xeljanz XRtofacitinib | Tofacitinib citrate 22 mg/1 | Tablet, Extended releaseOral | U.S. Pharmaceuticals | NDA | 63539-502 | 63539-0502-30 | — |
|---|
| Xelodacapecitabine | Capecitabine 500 mg/1 | Tablet, Film coatedOral | H2-Pharma, LLC | NDA | 61269-475 | 61269-0475-12 | — |
|---|
| Xelproslatanoprost | Latanoprost .05 mg/mL | Solution/ dropsOphthalmic, Topical | Sun Pharmaceutical Industries, Inc. | NDA | 47335-317 | 47335-0317-9047335-0317-9247335-0317-94+1 more | — |
|---|
| Xelria Fenorethindrone and ethinyl estradiol and ferrous fumarate | — | Kit | Xiromed LLC | ANDA | 70700-308 | 70700-0308-85 | — |
|---|
| Xelstrymdextroamphetamine | Dextroamphetamine 4.5 mg/1 | Patch, Extended releaseTransdermal | Noven Therapeutics, LLC | NDA | 68968-0205 | 68968-0205-03 | — |
|---|
| Xelstrymdextroamphetamine | Dextroamphetamine 9 mg/1 | Patch, Extended releaseTransdermal | Noven Therapeutics, LLC | NDA | 68968-0210 | 68968-0210-03 | — |
|---|
| Xelstrymdextroamphetamine | Dextroamphetamine 13.5 mg/1 | Patch, Extended releaseTransdermal | Noven Therapeutics, LLC | NDA | 68968-0215 | 68968-0215-03 | — |
|---|
| Xelstrymdextroamphetamine | Dextroamphetamine 18 mg/1 | Patch, Extended releaseTransdermal | Noven Therapeutics, LLC | NDA | 68968-0220 | 68968-0220-03 | — |
|---|
| Xembifyimmune globulin subcutaneous, human-klhw | Human immunoglobulin g 200 mg/mL | SolutionSubcutaneous | GRIFOLS USA, LLC | BLA | 13533-810 | 13533-0810-0513533-0810-1013533-0810-20+1 more | — |
|---|
| Xenazinetetrabenazine | Tetrabenazine 12.5 mg/1 | TabletOral | Lundbeck Pharmaceuticals LLC | NDA | 67386-421 | 67386-0421-01 | — |
|---|
| Xenazinetetrabenazine | Tetrabenazine 25 mg/1 | TabletOral | Lundbeck Pharmaceuticals LLC | NDA | 67386-422 | 67386-0422-01 | — |
|---|
| Xencare Inflamax Natural Topical Painmenthol, capsaicin | Capsaicin .025 g/100g; Levomenthol 4 g/100g | CreamTopical | Xenex Laboratories Inc. | OTC monograph drug | 68981-900 | 68981-0900-01 | — |
|---|
| Xenicalorlistat | Orlistat 120 mg/1 | CapsuleOral | H2-Pharma LLC | NDA | 61269-460 | 61269-0460-90 | — |
|---|
| Xenletalefamulin acetate | Lefamulin acetate 600 mg/1 | Tablet, CoatedOral | Meitheal Pharmaceuticals Inc. | NDA | 71288-037 | 71288-0037-10 | — |
|---|